J P Morgan Chase & Co set a €99.40 ($118.33) price objective on Gerresheimer AG (ETR:GXI) in a report released on Thursday. The firm currently has a buy rating on the stock.

Several other equities analysts have also issued reports on the stock. Independent Research GmbH set a €78.00 ($92.86) target price on shares of Gerresheimer AG and gave the company a neutral rating in a report on Wednesday, July 19th. DZ Bank AG restated a buy rating on shares of Gerresheimer AG in a report on Monday, July 17th. Goldman Sachs Group, Inc. (The) set a €73.00 ($86.90) target price on shares of Gerresheimer AG and gave the company a neutral rating in a report on Friday, July 14th. Deutsche Bank AG set a €82.00 ($97.62) target price on shares of Gerresheimer AG and gave the company a buy rating in a report on Friday, July 14th. Finally, Hauck & Aufhaeuser set a €80.00 ($95.24) target price on shares of Gerresheimer AG and gave the company a neutral rating in a report on Friday, July 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of Hold and an average price target of €79.80 ($95.00).

Gerresheimer AG (ETR:GXI) traded down 1.54% during mid-day trading on Thursday, hitting €64.97. 266 shares of the company were exchanged. Gerresheimer AG has a 12-month low of €64.00 and a 12-month high of €79.47. The company has a market capitalization of €2.04 billion and a P/E ratio of 18.00. The company’s 50-day moving average is €69.72 and its 200 day moving average is €72.52.

COPYRIGHT VIOLATION NOTICE: “Gerresheimer AG (GXI) Given a €99.40 Price Target at J P Morgan Chase & Co” was published by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/gerresheimer-ag-gxi-given-a-99-40-price-target-at-j-p-morgan-chase-co/1536218.html.

About Gerresheimer AG

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.